Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Polygalacic acid

🥰Excellent
Catalog No. T3767Cas No. 22338-71-2
Alias Virgaureagenin G

Polygalacic acid (Virgaureagenin G) is a triterpenoid isolated from the root of Polygala tenuifolia Willd that inhibits MMP expression. Polygalacic acid (Virgaureagenin G) can significantly improve the responsiveness of the cholinergic system, such as decreased acetylcholinesterase (AChE) activity, increased choline acetyltransferase (ChAT) activity, and increased acetylcholine (ACh) levels in the hippocampus and frontal cortex. Polygalacic acid (Virgaureagenin G) can also inhibit IL-1β-induced Wnt/β-catenin activation and mitogen-activated protein kinase (MAPK) signaling pathways in chondrocytes, and is used in osteoarthritis (OA) related research.

Polygalacic acid

Polygalacic acid

🥰Excellent
Purity: 98.92%
Catalog No. T3767Alias Virgaureagenin GCas No. 22338-71-2
Polygalacic acid (Virgaureagenin G) is a triterpenoid isolated from the root of Polygala tenuifolia Willd that inhibits MMP expression. Polygalacic acid (Virgaureagenin G) can significantly improve the responsiveness of the cholinergic system, such as decreased acetylcholinesterase (AChE) activity, increased choline acetyltransferase (ChAT) activity, and increased acetylcholine (ACh) levels in the hippocampus and frontal cortex. Polygalacic acid (Virgaureagenin G) can also inhibit IL-1β-induced Wnt/β-catenin activation and mitogen-activated protein kinase (MAPK) signaling pathways in chondrocytes, and is used in osteoarthritis (OA) related research.
Pack SizePriceAvailabilityQuantity
1 mg$91In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:98.92%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Polygalacic acid (Virgaureagenin G) is a triterpenoid isolated from the root of Polygala tenuifolia Willd that inhibits MMP expression. Polygalacic acid (Virgaureagenin G) can significantly improve the responsiveness of the cholinergic system, such as decreased acetylcholinesterase (AChE) activity, increased choline acetyltransferase (ChAT) activity, and increased acetylcholine (ACh) levels in the hippocampus and frontal cortex. Polygalacic acid (Virgaureagenin G) can also inhibit IL-1β-induced Wnt/β-catenin activation and mitogen-activated protein kinase (MAPK) signaling pathways in chondrocytes, and is used in osteoarthritis (OA) related research.
In vitro
Method: Polygalacic acid (Virgaureagenin G) (1,5,10,20,30,40,50μM) was used to treat BV2 and N2a cells, and Polygalacic acid (Virgaureagenin G) (50μM) was selected to treat Aβ42 (10,30,40μM). Treated BV2 cells and observed cell viability.
RESULTS Polygalacic acid (Virgaureagenin G) has no toxicity to BV2 and N2a cells; the conditioned medium pretreated with 50 μM Polygalacic acid (Virgaureagenin G) can significantly increase the viability of N2a cells and significantly reduce the apoptosis of N2a neurons induced by Aβ42. Mortality rate. [2]
In vivo
METHODS: Polygalacic acid (Virgaureagenin G) (3, 6 and 12 mg/kg, oral, 14 days), and intraperitoneal injection of scopolamine (1 mg/kg, 14 days) were used to induce memory impairment. Memory-related behaviors were assessed using the Morris water maze; cholinergic and neuroinflammatory activities were measured in brain tissue; superoxide dismutase activity malondialdehyde and reduced glutathione content in the brain were measured.
RESULTS Scopolamine treatment significantly increased escape latency, reduced the number of crossovers, and shortened the time spent in the target quadrant, and Polygalacic acid (Virgaureagenin G) reversed these scopolamine-induced effects; Polygalacic acid (Virgaureagenin G) significantly Improved cholinergic system reactivity, such as reduced acetylcholinesterase (AChE) activity, increased choline acetyltransferase (ChAT) activity, and increased acetylcholine (ACh) levels in the hippocampus and frontal cortex; Polygalacic acid (Virgaureagenin G) also showed Significantly improved neuroinflammation and oxidative stress in mice. [3]
AliasVirgaureagenin G
Chemical Properties
Molecular Weight504.7
FormulaC30H48O6
Cas No.22338-71-2
SmilesCC1(C)CC[C@@]2([C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@H]2C1)C(O)=O
Relative Density.1.23 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 91 mg/mL (180.3 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9814 mL9.9069 mL19.8138 mL99.0688 mL
5 mM0.3963 mL1.9814 mL3.9628 mL19.8138 mL
10 mM0.1981 mL0.9907 mL1.9814 mL9.9069 mL
20 mM0.0991 mL0.4953 mL0.9907 mL4.9534 mL
50 mM0.0396 mL0.1981 mL0.3963 mL1.9814 mL
100 mM0.0198 mL0.0991 mL0.1981 mL0.9907 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Polygalacic acid | purchase Polygalacic acid | Polygalacic acid cost | order Polygalacic acid | Polygalacic acid chemical structure | Polygalacic acid in vivo | Polygalacic acid in vitro | Polygalacic acid formula | Polygalacic acid molecular weight